Publications
By Year
Now showing items 221-240 of 5325 records
Novel loci and biomedical consequences of iron homoeostasis variation.
Elias Allara; Steven Bell; Rebecca Smith; Spencer J Keene; Dipender Gill; Liam Gaziano; Deisy Morselli Gysi; Feiyi Wang; Vinicius Tragante; Amy Mason; Savita Karthikeyan; R Thomas Lumbers; Emmanuela Bonglack; Willem Ouwehand; David J Roberts; Joseph Dowsett; Sisse Rye Ostrowski; Margit Hørup Larsen; Henrik Ullum; Ole Birger Pedersen; Søren Brunak; Karina Banasik; Christian Erikstrup; ; Jonathan Mitchell; Christian Fuchsberger; Cristian Pattaro; Peter P Pramstaller; Domenico Girelli; Mikko Arvas; Jarkko Toivonen; Sophie Molnos; Annette Peters; Ozren Polasek; Igor Rudan; Caroline Hayward; Ciara McDonnell; Nicola Pirastu; James F Wilson; Katja van den Hurk; Franke Quee; Luigi Ferrucci; Stefania Bandinelli; Toshiko Tanaka; Giorgia Girotto; Maria Pina Concas; Alessandro Pecori; Niek Verweij; Pim van der Harst; Yordi J van de Vegte; Lambertus A Kiemeney; Fred C Sweep; Tessel E Galesloot; Patrick Sulem; Daniel Gudbjartsson; Egil Ferkingstad; ; Luc Djousse; Kelly Cho; Michael Inouye; Stephen Burgess; Beben Benyamin; Konrad Oexle; Dorine Swinkels; Kari Stefansson; Magnus Magnusson; Andrea Ganna; Michael Gaziano; Kerry Ivey; John Danesh; Alexandre Pereira; Angela M Wood; Adam S Butterworth; Emanuele Di Angelantonio
COMMUNICATIONS BIOLOGY - 06 Dec 2024
Iron homoeostasis is tightly regulated, with hepcidin and soluble transferrin receptor (sTfR) playing significant roles. However, the genetic determinants of these traits and the biomedical consequences of iron homoeostasis variation are unclear. In a meta-analysis of 12 cohorts involving 91,675 participants, we found 43 genomic loci associated with either hepcidin or sTfR concentration, of whi...
Global analysis of endogenous protein disorder in cells.
Shouxiang Zhang; Tze Cin Owyong; Oana Sanislav; Lukas Englmaier; Xiaojing Sui; Geqing Wang; David W Greening; Nicholas A Williamson; Andreas Villunger; Jonathan M White; Begoña Heras; Wallace W H Wong; Paul R Fisher; Yuning Hong
NATURE METHODS - 25 Nov 2024
Disorder and flexibility in protein structures are essential for biological function but can also contribute to diseases, such as neurodegenerative disorders. However, characterizing protein folding on a proteome-wide scale within biological matrices remains challenging. Here we present a method using a bifunctional chemical probe, named TME, to capture in situ, enrich and quantify endogenous p...
Discriminating Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and comorbid conditions using metabolomics in UK Biobank.
Katherine Huang; Alex G C de Sá; Natalie Thomas; Robert D Phair; Paul R Gooley; David B Ascher; Christopher W Armstrong
COMMUNICATIONS MEDICINE - 26 Nov 2024
Diagnosing complex illnesses like Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is complicated due to the diverse symptomology and presence of comorbid conditions. ME/CFS patients often present with multiple health issues, therefore, incorporating comorbidities into research can provide a more accurate understanding of the condition's symptomatology and severity, to better reflect...
Estimating the cost of chronic kidney disease in Australia.
Sean Randall; Crystal M Y Lee; Elizabeth Thomas; Aron Chakera; Kevin E K Chai; Richard Varhol; Kanika Mehta; Ashley Irish; Johan Conradie; Narelle Hadlow; Delia Hendrie; James H Boyd; Suzanne Robinson
BMC HEALTH SERVICES RESEARCH - 26 Nov 2024
Chronic kidney disease (CKD) is a significant burden on health systems globally, with limited up-to-date information on health system costs, particularly for non-dialysis patients. This study estimates the direct healthcare costs of CKD within Australia. The study utilised the CKD.WA dataset, a linked repository for the state of Western Australia, containing public and private pathology, hospit...
Effects of interval training in cardiovascular disease populations: a clinical perspective.
Jennifer L Reed; Kimberley L Way; Carley D O'Neill; Isabela R Marçal; Tasuku Terada
01 Dec 2024
Nearly 20 years have elapsed since the first clinical trial investigated the impact of interval training on patients with cardiovascular disease (CVD). This clinical corner discusses the health outcomes of systematic reviews and meta-analyses and appropriately powered randomized clinical trials which have tested these interval training programs across various CVDs (i.e., coronary artery disease...
PRIMITI: A computational approach for accurate prediction of miRNA-target mRNA interaction.
Korawich Uthayopas; Alex G C de Sá; Azadeh Alavi; Douglas E V Pires; David B Ascher
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL - 01 Dec 2024
Current medical research has been demonstrating the roles of miRNAs in a variety of cellular mechanisms, lending credence to the association between miRNA dysregulation and multiple diseases. Understanding the mechanisms of miRNA is critical for developing effective diagnostic and therapeutic strategies. miRNA-mRNA interactions emerge as the most important mechanism to be understood despite the...
Current Emergency Medical Service Vasoactive Use for the Management of Shock.
Jason E Bloom; Vishal Goel; David Anderson; Susie Cartledge; Ziad Nehme; Jocasta Ball; Amminadab Eliakundu; William Chan; Derek P Chew; David M Kaye; Dion Stub
CRITICAL CARE EXPLORATIONS - 01 Dec 2024
We sought to describe the indications for vasoactive medication administration, hemodynamic treatment targets, and specific agents used by various international emergency medical service (EMS) providers. In March 2022, we sent an online survey comprising of 20 questions to Medical Directors of EMSs across Australia, the Asia Pacific region, and North America. A total of 108 EMS directors were e...
Left ventricular size and heart failure: A cardiac MRI assessment of 38,129 individuals from the UK Biobank.
Stephanie J Rowe; Ruidong Xiang; Elizabeth D Paratz; Fumihiko Takeuchi; Andre La Gerche
INTERNATIONAL JOURNAL OF CARDIOLOGY - 26 Oct 2024
Previous studies suggest that prevalent heart failure (HF) differs based on left ventricular ejection fraction (LVEF) and left ventricular (LV) chamber size. Furthermore, the prevalence of HF with preserved ejection fraction (HFpEF) is often considered approaching, or exceeding that of HF with reduced ejection fraction in the community. The aim of this study was to evaluate prevalent and incide...
Left Ventricular Summit Arrhythmias: State-of-the-Art Review of Anatomy, Mapping, and Ablation Strategies.
Souvik K Das; Joshua Hawson; Youlin Koh; Michael W Lim; Paolo D'Ambrosio; Sohaib A Virk; Danlu Liang; Troy Watts; Jairo Rodriguez Padilla; Kumaraswamy Nanthakumar; Saurabh Kumar; Michael Wong; Paul B Sparks; Ahmed Al-Kaisey; Bhupesh Pathik; Alex McLellan; Joseph B Morton; Peter M Kistler; Jonathan M Kalman; Geoffrey Lee; Robert D Anderson
JACC. CLINICAL ELECTROPHYSIOLOGY - 22 Oct 2024
The left ventricular summit (LVS) is the most common site of epicardial arrhythmias. Ablation of LVS arrhythmias continue to pose a challenge to the electrophysiologist because of its complex and intimate anatomical location. In this review, we undertake a detailed examination of the intricate anatomy of the LVS alongside a comprehensive synthesis of mapping and ablation strategies used to trea...
Outcomes After Percutaneous Coronary Intervention in Patients with Prior Coronary Artery Bypass Grafting.
Naomi S Cohen; Andrew E Ajani; Diem Dinh; David J Clark; Angela Brennan; Emilia Nan Tie; Misha Dagan; Garry Hamilton; Ernesto Oqueli; Melanie Freeman; Chin Hiew; Christopher M Reid; William Chan; Dion Stub; Stephen J Duffy;
THE AMERICAN JOURNAL OF CARDIOLOGY - 27 Oct 2024
In patients with prior CABG requiring subsequent PCI there is uncertainty whether bypass grafts or native coronary arteries should be targeted. We analysed data from 2,764 patients with prior CABG in the Melbourne Interventional Group registry (2005-2018), divided into two groups: those undergoing PCI to a native vessel (n=1,928) and those with PCI to a graft vessel (n=836).Patients with a graf...
Acute Inhibition of Drp1 Mitigates Adverse Cardiac Remodelling following Chronic Reperfused Myocardial Infarction.
Daniel G Donner; Anne M Kong; Jarmon G Lees; Helen Kiriazis; Aascha Brown; Yow K Tham; Jessica K Holien; Hsin-Hui Shen; Derek J Hausenloy; Shiang Y Lim
CARDIOVASCULAR DRUGS AND THERAPY - 21 Oct 2024
Behavioral and Psychosocial Dynamics in Diabetes Management: A Path Analysis to Examine the Influence of Acculturation in Arab Immigrant Communities.
Hamzah Alzubaidi; Vitor H Oliveira; Ward Saidawi; Raya Aljobowry; Jonathan E Shaw; Catarina Samorinha
21 Oct 2024
Type 2 diabetes mellitus (T2DM) prevalence is rising globally. Arab immigrants with T2DM, one of the least studied ethnic minorities, have a higher diabetes prevalence and more prominent management-related challenges compared with mainstream host societies. Acculturation's impact on self-care activities and diabetes distress (DD) is understudied globally. To examine how acculturation affects se...
Validation of serum non-invasive tests of liver fibrosis as prognostic markers of clinical outcomes in people with fatty liver disease in Australia.
Karl Vaz; William Kemp; Ammar Majeed; John Lubel; Dianna J Magliano; Kristen M Glenister; Lisa Bourke; David Simmons; Stuart K Roberts
24 Oct 2024
The validity of non-invasive tests (NITs) of liver fibrosis for the prediction of liver and mortality outcomes in an Australian cohort is unknown. We aimed to verify the utility of available NITs to predict overall and cause-specific mortality and major adverse liver outcome (MALO). This was an analysis from the Crossroads 1 clinic sub-study of a randomly sampled adult cohort from regional Aust...
Predictors in Youth of Adult Cardiovascular Events.
Joel Nuotio; Tomi T Laitinen; Costan G Magnussen; Alan R Sinaiko; Lydia A Bazzano; Stephen R Daniels; David R Jacobs; Noora Kartiosuo; Juha Koskinen; David P Burgner; Mika Kähönen; Olli T Raitakari; Julia Steinberger; Elaine M Urbina; Alison J Venn; Jorma S A Viikari; Jessica G Woo; Terence Dwyer; Markus Juonala
PEDIATRICS - 14 Oct 2024
Childhood risk factors are associated with cardiovascular events in adulthood. We compared the utility of a risk model based solely on nonlaboratory risk factors in adolescence versus a model that additionally included lipids to predict cardiovascular events in adulthood. The study comprised 11 550 participants from 7 longitudinal cohort studies in the United States, Australia, and Finland with...
Myocardial extracellular volume measurement using cardiac computed tomography.
Rahul G Muthalaly; Timothy Abrahams; Andrew Lin; Kush Patel; Sean Tan; Damini Dey; Donghee Han; Balaji K Tamarappoo; Stephen J Nicholls; Nitesh Nerlekar
THE INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING - 14 Oct 2024
Myocardial fibrosis is a common endpoint of many cardiac diseases and increasingly recognized as a predictor of heart failure, arrhythmia, and death. Recent studies have utilised cardiac computed tomography (CT) scans with delayed phase imaging to quantify diffuse fibrosis of the myocardium. CT extracellular volume (CT-ECV) measurement correlates well with CMR and histological myocardial fibros...
The mitral to aortic/pulmonary velocity-time integral ratio is a simple, feasible and accurate discriminator for echocardiographic evaluation of severe isolated mitral regurgitation.
Nitesh Nerlekar; Satish Ramkumar; Paul Maggiore; Justin Teng; Cengiz Cimenkaya; Kim Kuy Be; Angus Baumann; Stephen J Nicholls; Stuart Moir
THE INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING - 17 Oct 2024
Echocardiographic quantification of mitral regurgitation (MR) remains challenging, requiring dedicated image acquisition, and is limited by potential error from geometric assumptions of annular dimensions. Volume is a product of area and flow and assuming proportional mitral/aortic areas, an increased mitral-inflow volume compared to LV/RV-outflow semi-quantitatively represents greater MR regur...
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Eligibility and Prescription Rates in Patients Presenting With Recurrent Acute Coronary Syndromes.
William B He; Dylan Jape; Shane Nanayakkara; James A Shaw
HEART, LUNG & CIRCULATION - 17 Oct 2024
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are novel medications for reducing low-density lipoprotein cholesterol (LDL-C) levels. In 2020, the Australian Pharmaceutical Benefits Scheme (PBS) began subsidising PCSK9 inhibitors for secondary prevention of cardiovascular disease in patients with LDL-C >2.6 mmol/L despite statin and ezetimibe therapy. This criterion was expand...
Urinary metabolomics provide insights into coronary artery disease in individuals with type 1 diabetes.
Anni A Antikainen; Stefan Mutter; Valma Harjutsalo; Lena M Thorn; Per-Henrik Groop; Niina Sandholm;
CARDIOVASCULAR DIABETOLOGY - 26 Nov 2024
Type 1 diabetes increases the risk of coronary artery disease (CAD). High-throughput metabolomics may be utilized to identify metabolites associated with disease, thus, providing insight into disease pathophysiology, and serving as predictive markers in clinical practice. Urine is less tightly regulated than blood, and therefore, may enable earlier discovery of disease-associated markers. We st...
Polygenic Prediction of Recurrent Events After Early-Onset Myocardial Infarction.
Maddalena Ardissino; Elvezia Maria Paraboschi; Samuel A Lambert; Lois G Kim; Martin Kelemen; Giuseppe Maglietta; Antonio Crocamo; Giulia Magnani; Serena Bricoli; Luigi Vignali; Giampaolo Niccoli; Marco Tubaro; Libor Pastika; Arunashis Sau; Fu Siong Ng; Antonio de Marvao; Michael C Honigberg; Pradeep Natarajan; Adam J Nelson; Michael Inouye; Emanuele Di Angelantonio; Rosanna Asselta; Diego Ardissino; Adam S Butterworth
CIRCULATION. GENOMIC AND PRECISION MEDICINE - 29 Nov 2024
Myocardial infarction (MI) is a complex disease caused by both lifestyle and genetic factors. This study aims to investigate the predictive value of genetic risk, in addition to traditional cardiovascular risk factors, for recurrent events following early-onset MI. The Italian Genetic Study of Early-Onset Myocardial Infarction is a cohort study enrolling patients with MI before 45 years. Monoge...
Bioavailable testosterone and androgen receptor activation, but not total testosterone, are associated with muscle mass and strength in females.
Sarah E Alexander; Briana Gatto; Olivia E Knowles; Ross M Williams; Kinga N Fiebig; Paul Jansons; Paul A Della Gatta; Andrew Garnham; Nir Eynon; Glenn D Wadley; Brad Aisbett; Danielle Hiam; Séverine Lamon
THE JOURNAL OF PHYSIOLOGY - 11 Oct 2024
Testosterone, the major androgen, influences the reproductive and non-reproductive systems in males and females via binding to the androgen receptor (AR). Both circulating endogenous testosterone and muscle AR protein content are positively associated with muscle mass and strength in males, but there is no such evidence in females. Here, we tested whether circulating testosterone levels were as...
Show more...